Matches in Nanopublications for { ?s ?p "[A catalytic subunit of NADPH oxidase 1 (Nox1) is implicated to be involved in neoplastic progression in human epithelial cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP651413.RAV1MftbXtIrv7ZHzfZD9_wb0H6YUL75N2u_bPq7_hhho130_assertion description "[A catalytic subunit of NADPH oxidase 1 (Nox1) is implicated to be involved in neoplastic progression in human epithelial cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651413.RAV1MftbXtIrv7ZHzfZD9_wb0H6YUL75N2u_bPq7_hhho130_provenance.
- assertion description "[A catalytic subunit of NADPH oxidase 1 (Nox1) is implicated to be involved in neoplastic progression in human epithelial cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP884917.RAiHGeM1LHJ2K8XyJS0P3MFcZQZDAkp9dNvU6ixGdxGcI130_assertion description "[A catalytic subunit of NADPH oxidase 1 (Nox1) is implicated to be involved in neoplastic progression in human epithelial cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP884917.RAiHGeM1LHJ2K8XyJS0P3MFcZQZDAkp9dNvU6ixGdxGcI130_provenance.
- NP884946.RAuedoQQIrLgsKHktRwu92ZXb-BL81YHjmNalI8Pd5eSw130_assertion description "[A catalytic subunit of NADPH oxidase 1 (Nox1) is implicated to be involved in neoplastic progression in human epithelial cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP884946.RAuedoQQIrLgsKHktRwu92ZXb-BL81YHjmNalI8Pd5eSw130_provenance.
- NP920140.RAFaOO6ve487A-mB2B1y7Tpx-6F74dr9cDp_eqhSqQ2bE130_assertion description "[A catalytic subunit of NADPH oxidase 1 (Nox1) is implicated to be involved in neoplastic progression in human epithelial cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP920140.RAFaOO6ve487A-mB2B1y7Tpx-6F74dr9cDp_eqhSqQ2bE130_provenance.